{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:50:19Z","timestamp":1786992619597,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020916","name":"HUN-REN Hungarian Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jinorgbio.2024.112540","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:20:16Z","timestamp":1711444816000},"page":"112540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Complex formation of ML324, the histone demethylase inhibitor, with essential metal ions: Relationship between solution chemistry and anticancer activity"],"prefix":"10.1016","volume":"255","author":[{"given":"Hilda","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Jakusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00f3ra V.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Szak\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va A.","family":"Enyedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2024.112540_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1021\/acs.chemrev.8b00201","article-title":"Targeting metalloenzymes for therapeutic intervention","volume":"119","author":"Chen","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fchem.2020.00402","article-title":"Zinc-containing metalloenzymes: inhibition by metal-based anticancer agents","volume":"8","author":"Ye","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0020","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2174\/092986712800609706","article-title":"Iron chelators for the treatment of cancer","volume":"19","author":"Yu","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u2018copper that cancer\u2019","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1039\/C4MD00284A","article-title":"8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential","volume":"6","author":"Song","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.05.007","article-title":"8-Hydroxyquinolines in medicinal chemistry: a structural perspective","volume":"120","author":"Oliveri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104633","article-title":"Insights of 8-hydroxyquinolines: a novel target in medicinal chemistry","volume":"108","author":"Gupta","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0045","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1039\/C6MD00201C","article-title":"Evaluation of the effect of iodine substitution of 8-hydroxyquinoline on its platinum(ii) complex: cytotoxicity, cell apoptosis and telomerase inhibition","volume":"7","author":"Meng","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0050","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1080\/07391102.2019.1651219","article-title":"Five novel palladium(II) complexes of 8-hydroxyquinoline and amino acids with hydrophobic side chains: synthesis, characterization, cytotoxicity, DNA- and BSA-interaction studies","volume":"38","author":"Mohammadi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1039\/b902861g","article-title":"Advances in developing tris(8-quinolinolato)gallium(III) as an anticancer drug: critical appraisal and prospects","volume":"1","author":"Timerbaev","year":"2009","journal-title":"Metallomics"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Revel Ther."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrfmmm.2003.08.004","article-title":"Labile iron pool: the main determinant of cellular response to oxidative stress","volume":"531","author":"Kruszewski","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0075","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","article-title":"Targeting the achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance","volume":"114","author":"Szak\u00e1cs","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-19-1407","article-title":"Unshielding multidrug resistant cancer through selective iron depletion of P-glycoprotein-expressing cells","volume":"80","author":"Cserepes","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/cancers13010154","article-title":"Relation of metal-binding property and selective toxicity of 8-hydroxyquinoline derived mannich bases targeting multidrug resistant cancer cells","volume":"13","author":"Pape","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0090","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1021\/acs.jmedchem.2c00680","article-title":"Recent advances with KDM4 inhibitors and potential applications","volume":"65","author":"Wu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111563","article-title":"Design, synthesis and preliminary bioactivity evaluations of 8-hydroxyquinoline derivatives as matrix metalloproteinase (MMP) inhibitors","volume":"181","author":"Chen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00775-012-0873-4","article-title":"Potent inhibition of dinuclear zinc(II) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study","volume":"17","author":"Hanaya","year":"2012","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015535","article-title":"Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors","volume":"5","author":"King","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105961","article-title":"The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells","volume":"166","author":"Kleszcz","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109806","article-title":"Inhibition of histone demethylase KDM4 by ML324 induces apoptosis through the unfolded protein response and Bim upregulation in hepatocellular carcinoma cells","volume":"353","author":"Kim","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0120","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/v15010163","article-title":"Evaluation of histone demethylase inhibitor ML324 and acyclovir against cyprinid herpesvirus 3 infection","volume":"15","author":"Matsuoka","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41467-020-20629-8","article-title":"Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV pandemic response box","volume":"12","author":"Reader","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0130","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1096\/fj.201902584R","article-title":"Advances in histone demethylase KDM4 as cancer therapeutic targets","volume":"34","author":"Lee","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0135","series-title":"Probe Reports from the NIH Molecular Libraries Program [Internet]","article-title":"Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity","author":"Rai","year":"2012"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0140","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/ja01514a006","article-title":"Stability of metal chelates of 8-quinolinol-5-sulfonate","volume":"81","author":"Richard","year":"1959","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0145","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1042\/bj0540646","article-title":"Quantitative studies of the avidity of naturally occurring substances for trace metals. 3. Pteridines, riboflavin and purines","volume":"54","author":"Albert","year":"1953","journal-title":"Biochem. J."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0150","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1039\/C7DT00439G","article-title":"Comparative solution equilibrium studies of antitumor ruthenium(\u03b76-p-cymene) and rhodium(\u03b75-C5Me5) complexes of 8-hydroxyquinolines","volume":"46","author":"D\u00f6m\u00f6t\u00f6r","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/chem.200701024","article-title":"Preparation and study of new Poly-8-hydroxyquinoline chelators for ananti-alzheimer strategy","volume":"14","author":"Deraeve","year":"2008","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0160","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1039\/C8DT03088J","article-title":"Impact of copper and iron binding properties on the anticancer activity of 8-hydroxyquinoline derived Mannich bases","volume":"47","author":"Pape","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0165","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/ijms24010593","article-title":"Metal complexes of a 5-nitro-8-hydroxyquinoline-proline hybrid with enhanced water solubility targeting multidrug resistant cancer cells","volume":"24","author":"Pivarcsik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.09.022","article-title":"Iron and redox cycling. Do's and don'ts","volume":"133","author":"Koppenol","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0003-2670(01)80616-4","article-title":"A study of some problems in determining the stoicheiometric proton dissociation constants of complexes by potentiometric titrations using a glass electrode","volume":"38","author":"Irving","year":"1967","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0180","series-title":"The IUPAC Stability Constants Database. Academic Software (Version 5.5)","author":"SCQuery","year":"1993"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0185","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0190","series-title":"Computational Methods for the Determination of Stability Constants","first-page":"291","article-title":"I. Nagyp\u00e1l","author":"Z\u00e9k\u00e1ny","year":"1985"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0195","series-title":"The Hydrolysis of Cations","author":"Baes","year":"1976"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0200","series-title":"Hydrolysis of Metal Ions","first-page":"573","author":"Brown","year":"2016"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpba.2010.12.025","article-title":"Lipophilicity of kinetically labile metal complexes through the example of antidiabetic Zn(II) and VO(IV) compounds","volume":"54","author":"Enyedy","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03163097","article-title":"Automatic computer simulations of ESR spectra","volume":"10","author":"Rockenbauer","year":"1996","journal-title":"Appl. Magn. Reson."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0215","series-title":"Numerical Absorption Correction","author":"Higashi","year":"2002"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0220","series-title":"CrystalClear SM 1.4.0 Rigaku\/MSC Inc","year":"2008"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0225","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1107\/S1600576715001132","article-title":"Crystal structure determination and refinement via SIR2014","volume":"48","author":"Burla","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0230","series-title":"SHELXL-2013 Program for Crystal Structure Solution","year":"2013"},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0235","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S0021889802022112","article-title":"Single-crystal structure validation with the program PLATON","volume":"36","author":"Spek","year":"2003","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1107\/S002188980600731X","article-title":"Mercury: visualization and analysis of crystal structures","volume":"39","author":"Macrae","year":"2006","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1107\/S0021889804003528","article-title":"CIF applications. XV. enCIFer: a program for viewing, editing and visualizing CIFs","volume":"37","author":"Allen","year":"2004","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinorgbio.2014.12.015","article-title":"Synthesis and characterization of the anticancer and metal binding properties of novel pyrimidinylhydrazone derivatives","volume":"144","author":"Pape","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2024.112540_bb0260","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00204-019-02417-6","article-title":"Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen","volume":"93","author":"Windt","year":"2019","journal-title":"Arch. Toxicol."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013424000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013424000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T04:52:34Z","timestamp":1713156754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013424000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":52,"alternative-id":["S0162013424000631"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112540","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex formation of ML324, the histone demethylase inhibitor, with essential metal ions: Relationship between solution chemistry and anticancer activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2024.112540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112540"}}